HomeInsightsResults

Neuland Laboratories Ltd Quarterly Result

Neuland Laboratories Ltd Quarterly Result

stocks purchased

₹ 1.1 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

0.8 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Neuland Laboratories Ltd

NSE: NEULANDLAB

Net Profit

₹ 32.84

Last updated on: Nov 23, 2024

Key Highlights

  • The revenue of Neuland Laboratories Ltd for the Sep '24 is ₹ 315.18 crore as compare to the Jun '24 revenue of ₹ 465.03 crore. This represent the decline of -32.22373%.
  • The ebitda of Neuland Laboratories Ltd for the Sep '24 is ₹ 66.56 crore as compare to the Jun '24 ebitda of ₹ 148.79 crore. This represent the decline of -55.265812%.
  • The net profit of Neuland Laboratories Ltd for the Sep '24 is ₹ 32.84 crore as compare to the Jun '24 net profit of ₹ 97.87 crore. This represent the decline of -66.44528%.

Results Analysis

Market Price of Neuland Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Neuland Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202414904.25
21 Nov 202414793.55
19 Nov 202414864.3
18 Nov 202415024.85
14 Nov 202415547.45
13 Nov 202414661.25
12 Nov 202415327
11 Nov 202413787.3
08 Nov 202413799.9
07 Nov 202413791.7

Historical Revenue of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Neuland Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Neuland Laboratories Ltd

No data available

* All values are in crore

Neuland Laboratories Ltd News Hub

News

Neuland Laboratories Ltd leads losers in 'A' group

Hindustan Zinc Ltd, Five-Star Business Finance Ltd, Great Eastern Shipping Company Ltd and...

Read more

06 Nov 202415:00

News

Neuland Laboratories to declare Quarterly Result

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 6 Nov...

Read more

18 Oct 202409:43

News

Neuland Laboratories to hold board meeting

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 1 Aug...

Read more

18 Jul 202410:26

News

Neuland Laboratories AGM scheduled

Neuland Laboratories announced that the 40th Annual General Meeting(AGM) of the company wi...

Read more

11 May 202412:16

News

Board of Neuland Laboratories recommends Final Dividend

Neuland Laboratories announced that the Board of Directors of the Company at its meeting h...

Read more

10 May 202417:23

News

Neuland Laboratories schedules board meeting

Neuland Laboratories will hold a meeting of the Board of Directors of the Company on 10 Ma...

Read more

24 Apr 202411:24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Aug 2024

PPT

May 2022

Transcript

May 2021

Transcript

July 2020

Transcript

May 2020

Transcript

Jan 2020

Transcript

FAQ's For Neuland Laboratories Ltd Quarterly Result

What is the EPS of Neuland Laboratories Ltd stock?

The Earnings Per Share (EPS) of Neuland Laboratories Ltd is 205.86. An EPS is the amount of net income attributed to each share of a common stock.

How is Neuland Laboratories Ltd EPS calculated?

The EPS of Neuland Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Neuland Laboratories Ltd report its EPS?

Neuland Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Neuland Laboratories Ltd EPS?

Factors that influence the EPS of Neuland Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Neuland Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Neuland Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*